These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 848662)

  • 1. Indications and guidelines for mammographic examinations.
    Kalisher L; Schaffer D
    Am J Surg; 1977 Mar; 133(3):326-30. PubMed ID: 848662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Radiation risk associated with mammography screening examinations for women younger than 50 years of age].
    Nekolla EA; Griebel J; Brix G
    Z Med Phys; 2008; 18(3):170-9. PubMed ID: 18826160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk-based recommendations for mammographic screening for women in their forties.
    Gail M; Rimer B
    J Clin Oncol; 1998 Sep; 16(9):3105-14. PubMed ID: 9738582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimated risk of radiation-induced breast cancer from mammographic screening for young BRCA mutation carriers.
    Berrington de Gonzalez A; Berg CD; Visvanathan K; Robson M
    J Natl Cancer Inst; 2009 Feb; 101(3):205-9. PubMed ID: 19176458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammography in symptomatic and asymptomatic patients.
    Stomper PC; Gelman RS
    Hematol Oncol Clin North Am; 1989 Dec; 3(4):611-40. PubMed ID: 2691492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast imaging.
    Kopans DB; Meyer JE; Sadowsky N
    N Engl J Med; 1984 Apr; 310(15):960-7. PubMed ID: 6366562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of radiation-induced breast cancer from mammographic screening.
    Yaffe MJ; Mainprize JG
    Radiology; 2011 Jan; 258(1):98-105. PubMed ID: 21081671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer.
    Ringash J;
    CMAJ; 2001 Feb; 164(4):469-76. PubMed ID: 11233866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of radiation-induced breast cancers due to biennial mammographic screening in women aged 50-69 years is minimal.
    Hauge IH; Pedersen K; Olerud HM; Hole EO; Hofvind S
    Acta Radiol; 2014 Dec; 55(10):1174-9. PubMed ID: 24311702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Just the facts: mammography saves lives with little if any radiation risk to the mature breast.
    Kopans DB
    Health Phys; 2011 Nov; 101(5):578-82. PubMed ID: 21979544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammographic screening in BRCA1 mutation carriers postponed until age 40: Evaluation of benefits, costs and radiation risks using models.
    Obdeijn IM; Heijnsdijk EA; Hunink MG; Tilanus-Linthorst MM; de Koning HJ
    Eur J Cancer; 2016 Aug; 63():135-42. PubMed ID: 27318001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality.
    Tabár L; Vitak B; Chen HH; Yen MF; Duffy SW; Smith RA
    Cancer; 2001 May; 91(9):1724-31. PubMed ID: 11335897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammographic screening in women at increased risk of breast cancer after treatment of Hodgkin's disease.
    Kwong A; Hancock SL; Bloom JR; Pal S; Birdwell RL; Mariscal C; Ikeda DM
    Breast J; 2008; 14(1):39-48. PubMed ID: 18186864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The efficiency of mammographic mass screening (author's transl)].
    Richter B
    Rofo; 1978 Oct; 129(4):494-500. PubMed ID: 152250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term risk of false-positive screening results and subsequent biopsy as a function of mammography use.
    Blanchard K; Colbert JA; Kopans DB; Moore R; Halpern EF; Hughes KS; Smith BL; Tanabe KK; Michaelson JS
    Radiology; 2006 Aug; 240(2):335-42. PubMed ID: 16864665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biennial versus annual mammography and the risk of late-stage breast cancer.
    White E; Miglioretti DL; Yankaskas BC; Geller BM; Rosenberg RD; Kerlikowske K; Saba L; Vacek PM; Carney PA; Buist DS; Oestreicher N; Barlow W; Ballard-Barbash R; Taplin SH
    J Natl Cancer Inst; 2004 Dec; 96(24):1832-9. PubMed ID: 15601639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammography surveillance following breast cancer.
    Geller BM; Kerlikowske K; Carney PA; Abraham LA; Yankaskas BC; Taplin SH; Ballard-Barbash R; Dignan MB; Rosenberg R; Urban N; Barlow WE
    Breast Cancer Res Treat; 2003 Sep; 81(2):107-15. PubMed ID: 14572153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiogenic breast cancer effects of mammographic screening.
    Gohagan JK; Darby WP; Spitznagel EL; Monsees BS; Tome AE
    J Natl Cancer Inst; 1986 Jul; 77(1):71-6. PubMed ID: 3459927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mammographic surveillance of breast cancer patient relatives; implementation of guidelines formulated by the Netherlands College of General Practitioners].
    Duijm LE; Zaat JO; Guit GL
    Ned Tijdschr Geneeskd; 1998 Apr; 142(14):778-81. PubMed ID: 9646610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammographic surveillance of asymptomatic breast cancer relatives in general practice: rate of re-attendance and GP- and patient-related barriers.
    Duijm LE; Guit GL; Zaat JO
    Fam Pract; 1997 Dec; 14(6):450-4. PubMed ID: 9476075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.